What is United States Antimony's operating income?

United States Antimony's total operating income in 2025 was -$8.46 million, based on the following breakdown: Total Gross Profit: $9.87 million Total Operating Expenses: $18.33 million

United States Antimony (UAMY) Financials

$5.22 -0.24 (-4.31%)

Closing price 03:59 PM Eastern

Extended Trading

$5.18 -0.04 (-0.77%)

As of 05:05 PM Eastern

Compare

Annual Income Statements for United States Antimony

This table shows United States Antimony's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-0.89	-1.36	-1.18	0.82	-3.72	-3.34	-0.11	0.38	-6.36	-1.74	-4.35
Consolidated Net Income / (Loss)	-0.84	-1.31	-1.13	0.87	-3.67	-3.29	-0.06	0.43	-6.35	-1.73	-4.34
Net Income / (Loss) Continuing Operations	-0.84	-1.31	-1.13	0.87	-3.67	-3.29	-0.06	0.43	-6.35	-1.73	-4.34
Total Pre-Tax Income	-0.84	-1.01	-1.13	0.54	-3.67	-3.29	-0.06	0.44	-6.35	-1.73	-4.34
Total Operating Income	-0.81	-0.82	-0.96	0.55	-3.75	-3.30	-0.66	0.35	-7.07	-2.39	-8.46
Total Gross Profit	-0.41	0.54	0.28	0.00	-0.82	0.21	0.84	2.00	-3.34	3.47	9.87
Total Revenue	13	12	10	9.03	8.27	5.24	7.75	11	8.69	15	39
Operating Revenue	13	12	10	9.03	8.27	5.24	7.75	11	8.69	15	39
Total Cost of Revenue	14	11	9.95	9.03	9.08	5.03	6.91	9.05	12	11	29
Operating Cost of Revenue	14	11	9.95	9.03	9.08	5.03	6.91	9.05	12	11	29
Total Operating Expenses	0.40	1.35	1.24	-0.55	2.94	3.51	1.50	1.65	3.72	5.86	18
Selling, General & Admin Expense	1.02	0.99	0.86	1.28	1.01	1.54	1.24	1.17	3.51	5.85	19
Other Operating Expenses / (Income)	-0.62	0.36	0.37	-1.82	0.52	1.49	0.07	0.48	-	0.00	-0.47
Other Special Charges / (Income)	-	-	-	0.00	1.41	0.32	-	0.00	0.22	0.01	0.05
Total Other Income / (Expense), net	-0.03	-0.19	-0.17	-0.01	0.08	0.02	0.60	0.10	0.72	0.66	4.12
Interest & Investment Income	0.01	0.00	0.00	-	-	-	0.05	0.10	0.62	0.67	0.81
Other Income / (Expense), net	-0.04	-0.04	-0.07	0.09	0.16	0.04	0.44	-0.01	0.10	-0.01	3.31
Income Tax Expense	0.00	0.30	0.00	-0.33	-	-	0.00	0.02	0.00	0.00	0.00
Preferred Stock Dividends Declared	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	-0.01	0.01	0.01
Basic Earnings per Share	($0.01)	($0.02)	($0.02)	$0.01	($0.05)	($0.05)	-	$0.00	($0.06)	($0.02)	($0.04)
Weighted Average Basic Shares Outstanding	66.21M	66.78M	67.41M	67.98M	69.00M	72.51M	102.84M	106.29M	107.55M	108.59M	123.64M
Diluted Earnings per Share	($0.01)	($0.02)	($0.02)	$0.01	($0.05)	($0.05)	-	$0.00	($0.06)	($0.02)	($0.04)
Weighted Average Diluted Shares Outstanding	66.21M	66.78M	67.41M	68.10M	69.00M	72.51M	102.84M	106.29M	107.55M	108.59M	123.64M
Weighted Average Basic & Diluted Shares Outstanding	66.21M	66.78M	59.20M	82.50M	69.00M	72.51M	102.84M	-	-	114.63M	143.37M

This table shows United States Antimony's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-1.65	-3.56	-0.32	0.20	-0.73	-0.88	0.54	0.18	-4.78	-0.29	-11
Consolidated Net Income / (Loss)	-1.64	-3.56	-0.32	0.20	-0.73	-0.88	0.55	0.18	-4.78	-0.29	-11
Net Income / (Loss) Continuing Operations	-0.18	-6.43	-0.32	0.20	-0.73	-1.08	0.55	0.18	-4.78	-0.29	-11
Total Pre-Tax Income	-0.18	-5.04	-0.32	0.20	-0.73	-0.67	0.55	0.18	-4.78	-0.29	-11
Total Operating Income	-0.36	-6.88	-0.47	0.06	-0.89	-1.26	0.36	0.02	-4.92	-3.92	-7.52
Total Gross Profit	0.26	-4.38	0.59	1.25	0.42	1.31	2.37	2.84	2.01	2.65	1.11
Total Revenue	2.06	2.15	3.07	3.66	2.57	6.87	7.00	11	8.70	13	6.78
Operating Revenue	2.06	2.15	3.07	3.66	2.57	6.87	7.00	11	8.70	13	6.78
Total Cost of Revenue	1.81	6.54	2.48	2.41	2.15	5.56	4.63	7.69	6.69	10	5.67
Operating Cost of Revenue	1.81	6.54	2.48	2.41	2.15	5.56	4.63	7.69	6.69	10	5.67
Total Operating Expenses	0.62	0.79	1.06	1.19	1.31	2.61	2.01	2.82	6.93	6.57	8.63
Selling, General & Admin Expense	0.62	2.26	1.04	1.19	1.33	3.09	1.01	2.82	7.41	6.51	2.75
Other Operating Expenses / (Income)	-	-	-	-	0.00	-	1.00	-	-0.47	-	5.88
Other Special Charges / (Income)	0.00	0.22	0.02	0.00	-0.02	0.04	-0.00	0.00	-0.01	0.06	-0.00
Total Other Income / (Expense), net	0.18	-0.05	0.15	0.15	0.16	0.19	0.19	0.16	0.14	3.63	-3.76
Interest & Investment Income	0.18	0.15	0.15	0.15	0.16	0.21	0.19	0.15	0.15	0.31	0.33
Other Income / (Expense), net	0.00	-0.20	-0.00	-0.01	0.01	-0.02	-0.00	0.01	-0.01	3.32	-4.09
Other Gains / (Losses), net	-	-	-	-	-	-	0.00	-	-	-	-0.02
Preferred Stock Dividends Declared	0.00	-	0.00	0.00	0.00	-0.01	0.00	0.00	0.00	0.00	0.00
Basic Earnings per Share	$107,647,317.00	($322,555,106.06)	$0.00	$0.00	($0.01)	($324,786,274.02)	$0.00	$0.00	($0.04)	-	($0.08)
Weighted Average Basic Shares Outstanding	107.65M	107.55M	107.91M	108.44M	108.44M	108.59M	113.70M	118.26M	123.41M	123.64M	141.61M
Diluted Earnings per Share	$107,647,317.00	($322,555,106.06)	$0.00	$0.00	($0.01)	($325,290,416.02)	$0.00	$0.00	($0.04)	-	($0.08)
Weighted Average Diluted Shares Outstanding	107.65M	107.55M	107.91M	108.94M	108.44M	108.59M	122.39M	127.22M	123.41M	123.64M	141.61M
Weighted Average Basic & Diluted Shares Outstanding	107.65M	0.00	108.44M	108.44M	108.44M	114.63M	117.92M	120.72M	140.04M	143.37M	148.19M

This table details how cash moves in and out of United States Antimony's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	0.01	-0.12	0.02	0.02	0.06	0.55	24	-2.30	-7.64	6.32	12
Net Cash From Operating Activities	0.36	0.43	0.72	-0.66	-0.01	-1.31	-2.43	-0.25	-4.75	2.22	-9.69
Net Cash From Continuing Operating Activities	-0.06	0.38	0.54	-0.66	-0.01	-1.31	0.72	2.32	-5.23	2.24	-9.69
Net Income / (Loss) Continuing Operations	-0.84	-1.31	-1.13	0.87	-3.67	-3.29	-0.06	0.43	-6.35	-1.73	-4.34
Consolidated Net Income / (Loss)	-0.84	-1.31	-1.13	0.87	-3.67	-3.29	-0.06	0.43	-6.35	-1.73	-4.34
Depreciation Expense	0.93	1.00	0.97	0.90	0.90	0.89	0.88	0.91	0.96	1.09	1.17
Non-Cash Adjustments To Reconcile Net Income	0.07	0.11	0.21	-1.95	1.70	0.43	0.43	0.36	2.41	0.63	4.20
Changes in Operating Assets and Liabilities, net	0.19	0.56	0.58	-0.56	1.01	0.66	-0.53	0.62	-2.25	2.26	-11
Net Cash From Investing Activities	-1.70	-0.58	-0.37	0.90	-0.39	-0.24	-0.65	-1.79	-1.34	-0.04	-87
Net Cash From Continuing Investing Activities	-1.70	-0.58	-0.37	0.90	-0.39	-0.24	-0.65	-1.79	-1.34	-0.04	-87
Purchase of Property, Plant & Equipment	-1.71	-0.60	-0.37	-0.90	-0.79	-0.24	-0.65	-1.73	-1.53	-0.43	-28
Purchase of Investments	-	-	-	-	-	-	0.00	-16	-	0.00	-57
Sale of Property, Plant & Equipment	0.01	-	0.00	0.30	0.40	-	-	-	0.00	0.32	0.01
Other Investing Activities, net	0.00	0.01	-	-	-	0.00	-0.00	-	0.19	0.00	-2.50
Net Cash From Financing Activities	1.36	0.03	-0.33	-0.22	0.46	2.10	24	-0.27	-1.07	4.14	109
Net Cash From Continuing Financing Activities	1.36	0.03	-0.33	-0.22	0.46	2.10	24	-0.27	-1.07	4.14	109
Repayment of Debt	-0.09	-0.18	-0.21	-0.38	-0.16	-0.23	-0.14	-0.06	-0.28	-0.10	-0.13
Repurchase of Common Equity	-	-	-	-	-	-	0.00	-0.20	-	0.00	-0.45
Issuance of Common Equity	-	-	-	0.00	0.40	1.81	23	-	0.00	-	104
Other Financing Activities, net	1.32	0.17	-0.15	0.02	-0.03	0.07	0.58	-	-	1.48	5.85
Cash Interest Paid	-	0.01	0.01	0.02	0.02	0.02	0.01	0.02	0.01	0.01	0.02

This table details how cash moves in and out of United States Antimony's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	-0.51	1.44	-0.64	1.13	0.62	5.88	0.57	-13	13	12	-27
Net Cash From Operating Activities	0.47	-4.05	0.07	0.57	0.41	1.34	-1.73	-0.63	-3.86	-3.47	-12
Net Cash From Continuing Operating Activities	0.47	-4.53	-0.61	1.25	0.42	1.86	-1.73	-0.63	-3.86	-3.47	-12
Net Income / (Loss) Continuing Operations	-0.18	-6.43	0.00	-0.12	-0.73	-1.08	0.55	0.18	-4.78	-0.29	-11
Consolidated Net Income / (Loss)	-0.18	-6.43	-	-	-0.73	-	0.55	0.18	-4.78	-0.29	-11
Depreciation Expense	0.09	0.71	0.11	0.11	0.12	0.75	0.28	0.28	0.28	0.33	0.41
Non-Cash Adjustments To Reconcile Net Income	0.00	2.38	0.14	0.19	0.21	0.64	0.41	0.61	3.32	-0.14	8.87
Changes in Operating Assets and Liabilities, net	0.56	-1.19	-0.86	1.06	0.81	1.55	-2.97	-1.70	-2.68	-3.37	-10
Net Cash From Investing Activities	0.01	-0.00	-0.00	-0.10	0.24	-0.18	-0.86	-17	-19	-51	-13
Net Cash From Continuing Investing Activities	-0.14	-0.00	-0.00	-0.10	0.24	-0.18	-0.86	-17	-19	-51	-13
Purchase of Property, Plant & Equipment	-0.14	-0.19	-0.05	-0.10	-0.07	-0.21	-0.86	-6.53	-8.68	-12	-13
Acquisitions	-	-	-	-	-	-	0.00	-	-	-	-0.10
Purchase of Investments	-	-	-	-	-	-	0.00	-	-9.94	-37	0.00
Sale of Property, Plant & Equipment	-	-	0.00	-	0.31	0.00	0.00	-	0.01	0.00	0.00
Sale and/or Maturity of Investments	-	-	-	-	-	-	0.00	-	-	-	0.10
Net Cash From Financing Activities	-0.02	-0.21	-0.02	-0.02	-0.03	4.21	3.17	4.11	35	67	-2.63
Net Cash From Continuing Financing Activities	-0.02	-0.21	-0.02	-0.02	-0.03	4.21	3.17	4.11	35	67	-2.63
Repayment of Debt	-0.02	-0.21	-0.02	-0.02	-0.03	-0.03	-0.03	-0.03	-0.03	-0.03	-0.03
Repurchase of Common Equity	-	-	-	-	-	-	0.00	-	-	-0.04	-4.98
Issuance of Debt	-	-	-	-	-	-	2.39	2.67	33	-	1.34
Other Financing Activities, net	-	-	-	-	-	-	0.81	-	4.43	1.37	1.04
Cash Interest Paid	-	-	0.00	0.00	0.00	-	0.00	0.00	0.01	0.00	0.00

This table presents United States Antimony's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	18	18	17	18	14	13	35	35	28	35	154
Total Current Assets	2.14	1.69	1.56	1.90	1.28	1.81	24	22	14	21	55
Cash & Equivalents	0.13	0.01	0.03	0.06	0.12	0.67	21	19	12	18	30
Short-Term Investments	0.25	0.25	0.25	0.25	0.25	0.25	0.26	0.26	0.07	0.00	4.58
Note & Lease Receivable	-	-	-	-	-	-	-	-	-	0.00	2.50
Accounts Receivable	0.42	0.55	0.36	0.44	0.28	0.24	0.89	0.78	0.63	1.10	4.21
Inventories, net	1.09	0.86	0.91	0.76	0.63	0.65	1.06	1.38	1.39	1.25	13
Prepaid Expenses	-	-	-	-	-	-	0.00	0.14	0.09	0.16	0.43
Other Current Assets	0.24	0.02	0.00	0.40	-	-	-	-	-	-	0.00
Plant, Property, & Equipment, net	16	16	15	15	12	11	11	12	13	13	42
Total Noncurrent Assets	0.09	0.38	0.44	0.43	0.23	0.27	0.30	0.95	0.56	1.07	57
Long-Term Investments	0.08	0.06	0.06	0.06	0.06	0.06	-	-	-	0.00	56
Other Noncurrent Operating Assets	0.02	0.31	0.37	0.37	0.17	0.21	0.30	0.95	0.56	0.97	0.38
Other Noncurrent Nonoperating Assets	-	-	-	-	-	-	-	-	-	0.10	0.16
Total Liabilities & Shareholders' Equity	18	18	17	18	14	13	35	35	28	35	154
Total Liabilities	5.80	6.42	6.75	6.13	5.23	6.11	2.63	2.83	2.57	6.04	13
Total Current Liabilities	2.43	3.38	3.93	3.52	3.98	4.48	2.07	2.22	0.90	4.01	10
Short-Term Debt	0.31	0.56	0.74	0.89	0.25	0.15	0.01	0.09	0.03	0.13	0.14
Accounts Payable	1.66	1.81	2.30	2.02	2.69	2.10	1.44	0.63	0.46	1.55	6.92
Accrued Expenses	0.14	0.12	0.17	0.35	0.64	0.64	0.27	0.71	0.41	1.60	3.08
Other Current Liabilities	0.01	0.19	0.04	0.06	0.40	0.46	0.35	-	0.00	0.63	0.03
Total Noncurrent Liabilities	3.37	3.04	2.82	2.61	1.25	1.64	0.56	0.61	1.68	2.04	2.79
Long-Term Debt	1.72	1.47	1.24	1.03	0.08	0.48	0.20	0.22	0.00	0.20	0.06
Asset Retirement Reserve & Litigation Obligation	-	-	-	-	-	-	0.30	0.33	1.64	1.71	2.72
Other Noncurrent Operating Liabilities	1.65	1.57	1.58	1.59	1.17	1.16	0.06	0.06	0.04	0.13	0.01
Commitments & Contingencies	-	0.00	0.00	0.00	0.00	-	-	-	-	0.00	0.00
Total Equity & Noncontrolling Interests	12	11	10	11	8.47	7.19	32	32	26	29	141
Total Preferred & Common Equity	12	11	10	11	8.47	7.19	32	32	26	29	141
Preferred Stock	0.00	0.00	0.00	0.03	0.03	0.03	0.03	0.03	0.01	0.01	0.01
Total Common Equity	12	11	10	11	8.44	7.16	32	32	26	29	141
Common Stock	37	37	37	37	38	40	65	65	65	70	187
Retained Earnings	-24	-25	-27	-26	-29	-33	-33	-33	-39	-41	-45
Treasury Stock	-	-	-	-	-	-	0.00	-0.20	-	0.00	-0.57

This table presents United States Antimony's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	32	31	28	29	30	39	47	80	148
Total Current Assets	18	17	14	15	15	25	18	32	48
Cash & Equivalents	14	13	12	12	13	19	5.71	18	3.22
Short-Term Investments	0.26	0.26	0.02	0.02	0.02	-	1.26	1.27	4.62
Note & Lease Receivable	-	-	-	-	-	-	-	-	2.45
Accounts Receivable	1.31	1.39	1.06	1.39	0.79	1.97	2.54	1.90	2.51
Inventories, net	2.35	1.88	0.65	0.46	0.97	3.99	6.81	8.41	22
Prepaid Expenses	0.38	0.24	0.12	0.29	0.18	0.13	1.35	1.88	0.73
Other Current Assets	-	-	0.22	0.05	0.07	-	-	-	13
Plant, Property, & Equipment, net	13	13	7.71	7.80	7.75	13	20	28	47
Total Noncurrent Assets	1.22	1.31	6.29	6.52	7.00	1.09	10	20	53
Long-Term Investments	-	-	-	-	-	-	8.83	19	52
Other Noncurrent Operating Assets	1.22	1.31	0.07	6.52	0.88	1.09	1.27	0.94	0.37
Other Noncurrent Nonoperating Assets	-	-	6.22	-	6.12	-	-	-	0.16
Total Liabilities & Shareholders' Equity	32	31	28	29	30	39	47	80	148
Total Liabilities	1.54	1.85	2.60	3.23	4.63	6.91	9.99	8.13	16
Total Current Liabilities	0.98	1.28	0.91	1.25	2.40	4.72	8.00	6.26	13
Short-Term Debt	0.08	0.06	0.01	0.13	0.13	0.13	0.13	0.14	0.14
Accounts Payable	0.41	0.61	0.40	0.54	1.21	3.21	5.75	4.22	9.67
Accrued Expenses	0.27	0.33	0.34	0.43	0.43	0.80	1.52	1.79	3.53
Other Current Liabilities	0.22	0.28	-	-	0.48	0.58	0.59	0.12	0.03
Total Noncurrent Liabilities	0.57	0.57	1.69	1.98	2.22	2.19	2.00	1.87	2.79
Long-Term Debt	0.18	0.18	-	0.26	0.23	0.16	0.13	0.09	0.02
Asset Retirement Reserve & Litigation Obligation	0.34	0.34	1.12	1.14	1.16	1.73	1.75	1.77	2.75
Other Noncurrent Operating Liabilities	0.04	0.04	0.04	0.04	0.30	0.29	0.12	0.01	0.01
Commitments & Contingencies	-	-	-	-	-	-	-	0.00	0.00
Total Equity & Noncontrolling Interests	31	29	25	26	25	33	38	72	132
Total Preferred & Common Equity	31	29	25	26	25	33	38	72	132
Preferred Stock	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Total Common Equity	31	29	25	26	25	33	37	72	132
Common Stock	65	65	65	65	65	73	78	117	195
Retained Earnings	-34	-36	-40	-40	-40	-41	-40	-45	-57
Treasury Stock	0.00	0.00	-	-	-	-	-	-0.51	-6.37

This table displays calculated financial ratios and metrics derived from United States Antimony's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	66,316,278.00	66,866,278.00	67,488,153.00	68,227,171.00	69,661,436.00	75,949,757.00	106,117,844.00	106,373,341.00	107,647,317.00	-	140,035,604.00
DEI Adjusted Shares Outstanding	66,316,278.00	66,866,278.00	67,488,153.00	68,227,171.00	69,661,436.00	75,949,757.00	106,117,844.00	106,373,341.00	107,647,317.00	-	140,035,604.00
DEI Earnings Per Adjusted Shares Outstanding	-0.01	-0.02	-0.02	0.01	-0.05	-0.04	0.00	0.00	-0.06	-	-0.03
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Net Operating Profit after Tax (NOPAT)	-0.57	-0.57	-0.67	0.88	-2.63	-2.31	-0.46	0.34	-4.95	-1.67	-5.92
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-19.37%	-5.79%	-4.20%
Earnings before Interest and Taxes (EBIT)	-0.84	-0.85	-1.03	0.64	-3.59	-3.27	-0.22	0.34	-6.97	-2.40	-5.15
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	0.09	0.22	0.03	1.63	-2.64	-2.38	0.66	1.25	-6.01	-1.31	-3.98
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1.17	0.41	0.37	-0.08	1.98	-0.78	-4.58	-2.35	-4.88	1.25	-45
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	14	13	12	13	8.37	6.84	11	14	14	11	50
Increase / (Decrease) in Invested Capital	0.61	-0.98	-1.04	0.96	-4.60	-1.53	4.12	2.69	-0.07	-2.92	39
Book Value per Share	$0.19	$0.17	$0.15	$0.17	$0.12	$0.09	$0.30	$0.30	$0.24	$0.26	$1.01
Tangible Book Value per Share	$0.19	$0.17	$0.15	$0.17	$0.12	$0.09	$0.30	$0.30	$0.24	$0.26	$1.01
Total Capital	14	13	12	13	8.80	7.82	33	32	26	29	141
Total Debt	2.03	2.03	1.98	1.92	0.33	0.63	0.22	0.31	0.03	0.33	0.20
Total Long-Term Debt	1.72	1.47	1.24	1.03	0.08	0.48	0.20	0.22	0.00	0.20	0.06
Net Debt	1.57	1.71	1.64	1.55	-0.10	-0.35	-21	-19	-12	-18	-91
Capital Expenditures (CapEx)	1.70	0.60	0.37	0.60	0.39	0.24	0.65	1.73	1.53	0.11	28
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-0.37	-1.39	-1.91	-1.03	-2.81	-3.44	-0.11	0.17	1.23	-1.47	9.63
Debt-free Net Working Capital (DFNWC)	0.02	-1.13	-1.63	-0.72	-2.44	-2.52	22	19	13	17	45
Net Working Capital (NWC)	-0.29	-1.69	-2.37	-1.61	-2.70	-2.67	21	19	13	17	45
Net Nonoperating Expense (NNE)	0.27	0.74	0.46	0.01	1.05	0.97	-0.40	-0.09	1.40	0.06	-1.58
Net Nonoperating Obligations (NNO)	1.57	1.71	1.64	1.55	-0.10	-0.35	-21	-18	-12	-18	-91
Total Depreciation and Amortization (D&A)	0.93	1.07	1.06	0.99	0.95	0.89	0.88	0.91	0.96	1.09	1.17
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.01)	($0.02)	($0.02)	$0.01	($0.05)	($0.05)	$0.00	$0.00	($0.06)	($0.02)	($0.04)
Adjusted Weighted Average Basic Shares Outstanding	66.32M	67.49M	59.20M	67.98M	69.00M	102.80M	106.24M	106.29M	107.55M	108.59M	123.64M
Adjusted Diluted Earnings per Share	($0.01)	($0.02)	($0.02)	$0.01	($0.05)	($0.05)	$0.00	$0.00	($0.06)	($0.02)	($0.04)
Adjusted Weighted Average Diluted Shares Outstanding	66.32M	67.49M	59.20M	68.10M	69.00M	102.80M	106.24M	106.29M	107.55M	108.59M	123.64M
Adjusted Basic & Diluted Earnings per Share	($0.01)	($0.02)	($0.02)	$0.01	($0.05)	($0.05)	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	66.21M	66.78M	67.41M	82.50M	69.00M	72.51M	102.84M	0.00	0.00	114.63M	143.37M
Normalized Net Operating Profit after Tax (NOPAT)	-0.57	-0.57	-0.67	0.38	-1.64	-2.09	-0.46	0.34	-4.80	-1.67	-5.89
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-

This table displays calculated financial ratios and metrics derived from United States Antimony's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	107,647,317.00	107,647,317.00	107,647,317.00	108,438,984.00	108,438,984.00	-	229,264,738.00	117,922,971.00	120,723,320.00	140,035,604.00	143,371,936.00
DEI Adjusted Shares Outstanding	107,647,317.00	107,647,317.00	107,647,317.00	108,438,984.00	108,438,984.00	-	229,264,738.00	117,922,971.00	120,723,320.00	140,035,604.00	143,371,936.00
DEI Earnings Per Adjusted Shares Outstanding	-0.02	-0.03	0.00	0.00	-0.01	-	0.00	0.00	-0.04	0.00	-0.08
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-16.25%	52.47%	38.95%	61.71%	24.65%	219.08%	127.86%	187.34%	238.31%	-	-3.08%
EBITDA Growth	-196.37%	-985.90%	-149.68%	256.46%	-185.68%	91.52%	273.17%	84.05%	-507.49%	-	-1,859.47%
EBIT Growth	-1,122.81%	-783.25%	-170.65%	126.66%	-144.93%	81.85%	174.82%	-47.35%	-457.04%	-	-3,375.31%
NOPAT Growth	-520.94%	-701.26%	-226.04%	140.55%	-144.97%	81.64%	208.71%	-64.28%	-451.86%	-	-1,569.88%
Net Income Growth	-3,362.82%	-362.85%	60.00%	160.27%	55.76%	75.20%	269.32%	-10.47%	-557.13%	-	-2,166.60%
EPS Growth	358,824,390,100.00%	-3,225,551,060,700.00%	-100.00%	-100.00%	-100.00%	-0.85%	0.00%	0.00%	-300.00%	-	0.00%
Operating Cash Flow Growth	165.46%	-1,389.49%	107.07%	327.85%	-13.01%	132.96%	-2,759.34%	-210.91%	-1,039.62%	-	-597.38%
Free Cash Flow Firm Growth	-32.80%	-44.30%	300.65%	152.32%	353.80%	142.89%	-177.60%	-383.12%	-451.68%	-	-991.64%
Invested Capital Growth	23.55%	-0.53%	-49.42%	-15.45%	-56.24%	-21.50%	77.13%	52.98%	372.19%	-	410.04%
Revenue Q/Q Growth	-8.90%	4.37%	42.65%	19.23%	-29.78%	183.84%	1.87%	50.36%	-17.32%	-	-47.94%
EBITDA Q/Q Growth	-153.60%	-2,278.06%	94.23%	145.00%	-563.05%	25.11%	217.80%	-52.17%	-1,628.37%	-	-4,005.14%
EBIT Q/Q Growth	-89.42%	-1,860.25%	93.32%	110.74%	-1,840.22%	-52.91%	127.56%	-92.44%	-18,510.54%	-	-1,834.56%
NOPAT Q/Q Growth	-84.32%	-1,791.84%	93.16%	117.01%	-1,213.62%	-49.51%	140.48%	-94.41%	-17,304.12%	-	-91.78%
Net Income Q/Q Growth	-388.77%	-116.49%	90.93%	162.83%	-458.75%	-21.36%	161.90%	-66.78%	-2,733.20%	-	-3,836.67%
EPS Q/Q Growth	0.00%	-399.64%	100.00%	0.00%	0.00%	-399.98%	100.00%	0.00%	0.00%	-	0.00%
Operating Cash Flow Q/Q Growth	290.31%	-957.70%	101.60%	770.31%	-27.34%	198.03%	-229.41%	63.70%	-515.54%	-	-247.51%
Free Cash Flow Firm Q/Q Growth	34.98%	-42.45%	256.31%	-63.86%	215.37%	-76.02%	-382.83%	-31.86%	-291.74%	-	-50.92%
Invested Capital Q/Q Growth	-4.98%	-15.89%	-41.62%	81.19%	-50.82%	50.88%	31.75%	56.49%	51.79%	-	44.24%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	12.52%	-203.59%	19.19%	34.13%	16.48%	19.06%	33.88%	26.96%	23.14%	-	16.35%
EBITDA Margin	-12.99%	-295.95%	-11.96%	4.51%	-29.77%	-7.86%	9.09%	2.89%	-53.45%	-	-165.04%
Operating Margin	-17.63%	-319.52%	-15.31%	1.53%	-34.64%	-18.39%	5.11%	0.19%	-56.51%	-	-110.81%
EBIT Margin	-17.52%	-328.99%	-15.42%	1.39%	-34.42%	-18.71%	5.06%	0.25%	-56.67%	-	-171.09%
Profit (Net Income) Margin	-79.69%	-165.32%	-10.51%	5.54%	-28.28%	-12.85%	7.81%	1.73%	-54.94%	-	-166.49%
Tax Burden Percent	889.97%	70.64%	100.00%	100.00%	100.00%	132.01%	100.00%	100.00%	100.00%	-	100.14%
Interest Burden Percent	51.12%	71.14%	68.15%	398.64%	82.18%	52.02%	154.23%	677.82%	96.95%	-	97.17%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Return on Invested Capital (ROIC)	-6.72%	-142.83%	-8.68%	1.07%	-23.95%	-15.87%	8.78%	0.27%	-62.36%	-	-70.71%
ROIC Less NNEP Spread (ROIC-NNEP)	1.58%	-151.16%	-8.72%	-0.10%	-23.28%	-15.88%	7.74%	-0.93%	-57.62%	-	-55.41%
Return on Net Nonoperating Assets (RNNOA)	-0.84%	79.45%	5.08%	0.05%	13.32%	8.77%	-4.81%	0.40%	33.58%	-	26.55%
Return on Equity (ROE)	-7.56%	-63.38%	-3.60%	1.11%	-10.64%	-7.10%	3.98%	0.67%	-28.78%	-	-44.16%
Cash Return on Invested Capital (CROIC)	-26.08%	-35.82%	18.71%	-17.46%	28.85%	10.28%	-65.62%	-48.04%	-149.58%	-	-161.13%
Operating Return on Assets (OROA)	-4.20%	-91.09%	-4.84%	0.50%	-13.00%	-8.91%	2.83%	0.17%	-32.93%	-	-71.23%
Return on Assets (ROA)	-19.09%	-45.77%	-3.30%	1.98%	-10.68%	-6.12%	4.36%	1.16%	-31.93%	-	-69.32%
Return on Common Equity (ROCE)	-7.56%	-63.34%	-3.60%	1.11%	-10.63%	-7.10%	3.98%	0.67%	-28.77%	-	-44.15%
Return on Equity Simple (ROE_SIMPLE)	-12.23%	0.00%	-23.08%	0.00%	0.00%	0.00%	-2.64%	0.00%	0.00%	-	0.00%
Net Operating Profit after Tax (NOPAT)	-0.25	-4.82	-0.33	0.06	-0.62	-0.88	0.36	0.02	-3.44	-2.74	-5.26
NOPAT Margin	-12.34%	-223.66%	-10.72%	1.53%	-24.25%	-12.87%	5.11%	0.19%	-39.55%	-	-77.56%
Net Nonoperating Expense Percent (NNEP)	-8.30%	8.33%	0.04%	1.17%	-0.67%	0.01%	1.05%	1.20%	-4.74%	-	-15.30%
Return On Investment Capital (ROIC_SIMPLE)	-	-18.85%	-1.30%	0.21%	-2.45%	-3.06%	1.09%	0.05%	-4.78%	-1.94%	-3.98%
Cost of Revenue to Revenue	87.48%	303.59%	80.81%	65.87%	83.52%	80.94%	66.12%	73.04%	76.86%	-	83.65%
SG&A Expenses to Revenue	30.15%	104.86%	33.93%	32.60%	51.75%	44.97%	28.77%	26.77%	85.14%	-	40.52%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Operating Expenses to Revenue	30.15%	36.58%	34.50%	32.60%	51.12%	37.95%	28.77%	26.77%	79.64%	-	127.16%
Earnings before Interest and Taxes (EBIT)	-0.36	-7.09	-0.47	0.05	-0.89	-1.29	0.35	0.03	-4.93	-0.60	-12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-0.27	-6.37	-0.37	0.17	-0.77	-0.54	0.64	0.30	-4.65	-0.27	-11
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.37	1.05	1.06	1.42	3.29	6.71	7.74	6.86	10.43	-	9.49
Price to Tangible Book Value (P/TBV)	1.37	1.05	1.06	1.42	3.29	6.71	7.74	6.86	10.43	-	9.49
Price to Revenue (P/Rev)	4.99	3.08	2.82	3.33	7.22	12.85	13.37	9.99	23.49	-	32.06
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.66	1.10	1.89	1.70	9.93	16.33	16.64	10.99	21.29	-	16.64
Enterprise Value to Revenue (EV/Rev)	3.37	1.71	1.57	2.23	6.12	11.65	12.38	9.39	22.29	-	30.52
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	78.37	548.49	0.00	0.00	-	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	6.78	0.00	20.95	139.66	0.00	0.00	0.00	-	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.01	0.00	0.00	0.02	0.01	0.01	0.01	0.01	0.00	-	0.00
Long-Term Debt to Equity	0.01	0.00	0.00	0.01	0.01	0.01	0.01	0.00	0.00	-	0.00
Financial Leverage	-0.53	-0.53	-0.58	-0.44	-0.57	-0.55	-0.62	-0.43	-0.58	-	-0.48
Leverage Ratio	1.06	1.09	1.08	1.08	1.12	1.16	1.16	1.21	1.13	-	1.14
Compound Leverage Factor	0.54	0.78	0.73	4.32	0.92	0.60	1.80	8.20	1.10	-	1.11
Debt to Total Capital	0.83%	0.11%	0.03%	1.50%	1.41%	1.13%	0.90%	0.69%	0.32%	-	0.12%
Short-Term Debt to Total Capital	0.21%	0.11%	0.03%	0.50%	0.51%	0.46%	0.41%	0.36%	0.19%	-	0.10%
Long-Term Debt to Total Capital	0.61%	0.00%	0.00%	1.00%	0.90%	0.68%	0.49%	0.34%	0.13%	-	0.02%
Preferred Equity to Total Capital	0.03%	0.04%	0.04%	0.04%	0.04%	0.03%	0.03%	0.02%	0.01%	-	0.01%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Common Equity to Total Capital	99.14%	99.85%	99.94%	98.46%	98.55%	98.84%	99.07%	99.28%	99.67%	-	99.87%
Debt to EBITDA	-1.10	0.00	0.00	-0.06	-0.05	-0.25	-0.95	-1.54	-0.06	-	-0.01
Net Debt to EBITDA	58.57	1.99	1.68	1.76	1.72	13.66	59.96	91.16	9.47	-	3.80
Long-Term Debt to EBITDA	-0.81	0.00	0.00	-0.04	-0.03	-0.15	-0.52	-0.75	-0.02	-	0.00
Debt to NOPAT	-0.33	-0.01	0.00	-0.07	-0.06	-0.20	-0.27	-0.23	-0.06	-	-0.01
Net Debt to NOPAT	17.66	2.41	2.16	2.24	2.20	10.72	16.96	13.88	9.75	-	5.26
Long-Term Debt to NOPAT	-0.25	0.00	0.00	-0.05	-0.04	-0.12	-0.15	-0.11	-0.02	-	0.00
Altman Z-Score	12.10	4.32	5.07	5.80	9.63	18.28	21.59	15.03	55.02	-	46.24
Noncontrolling Interest Sharing Ratio	0.06%	0.06%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.02%	-	0.01%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	12.99	15.68	15.46	11.67	6.24	5.16	5.26	2.21	5.08	-	3.62
Quick Ratio	11.34	14.04	14.37	11.03	5.73	4.82	4.39	1.19	3.43	-	0.96
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-3.33	-4.75	7.42	2.68	8.45	2.04	-5.76	-7.59	-30	-42	-63
Operating Cash Flow to CapEx	333.20%	-2,119.63%	123.36%	577.44%	0.00%	648.56%	-200.61%	-9.61%	-44.58%	-	-95.87%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.24	0.28	0.31	0.36	0.38	0.48	0.56	0.67	0.58	-	0.42
Accounts Receivable Turnover	5.60	12.33	6.92	8.11	10.50	16.77	12.45	13.07	23.69	-	17.41
Inventory Turnover	5.33	8.72	11.23	9.41	9.55	8.72	5.86	5.19	5.00	-	2.34
Fixed Asset Turnover	0.66	0.68	0.94	1.05	1.11	1.13	1.78	1.87	1.78	-	1.30
Accounts Payable Turnover	12.31	22.17	20.51	27.83	14.94	11.46	7.54	6.01	8.63	-	4.73
Days Sales Outstanding (DSO)	65.20	29.59	52.76	45.02	34.75	21.77	29.32	27.93	15.41	-	20.97
Days Inventory Outstanding (DIO)	68.47	41.86	32.51	38.77	38.21	41.87	62.24	70.28	73.06	-	156.04
Days Payable Outstanding (DPO)	29.64	16.46	17.80	13.11	24.44	31.86	48.38	60.77	42.30	-	77.24
Cash Conversion Cycle (CCC)	104.02	55.00	67.47	70.68	48.51	31.78	43.19	37.43	46.17	-	99.77
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	16	14	7.93	14	7.06	11	14	22	33	50	72
Invested Capital Turnover	0.54	0.64	0.81	0.70	0.99	1.23	1.72	1.42	1.58	-	0.91
Increase / (Decrease) in Invested Capital	3.08	-0.07	-7.75	-2.62	-9.08	-2.92	6.11	7.61	26	39	58
Enterprise Value (EV)	27	15	15	24	70	174	234	242	710	-	1,192
Market Capitalization	40	27	27	36	83	192	252	257	748	-	1,252
Book Value per Share	$0.27	$0.24	$0.24	$0.24	$0.23	$0.26	$0.28	$0.32	$0.59	$1.01	$0.92
Tangible Book Value per Share	$0.27	$0.24	$0.24	$0.24	$0.23	$0.26	$0.28	$0.32	$0.59	$1.01	$0.92
Total Capital	29	26	25	26	25	29	33	38	72	141	132
Total Debt	0.24	0.03	0.01	0.39	0.36	0.33	0.30	0.26	0.23	0.20	0.16
Total Long-Term Debt	0.18	0.00	0.00	0.26	0.23	0.20	0.16	0.13	0.09	0.06	0.02
Net Debt	-13	-12	-12	-12	-13	-18	-19	-16	-38	-91	-60
Capital Expenditures (CapEx)	0.14	0.19	0.05	0.10	-0.24	0.21	0.86	6.53	8.67	12	13
Debt-free, Cash-free Net Working Capital (DFCFNWC)	2.23	1.23	1.14	1.08	-0.26	-1.47	1.41	2.85	5.93	9.63	27
Debt-free Net Working Capital (DFNWC)	15	13	13	13	13	17	20	9.81	26	45	35
Net Working Capital (NWC)	15	13	13	13	13	17	20	9.68	26	45	35
Net Nonoperating Expense (NNE)	1.39	-1.26	-0.01	-0.15	0.10	-0.00	-0.19	-0.16	1.34	-2.46	6.03
Net Nonoperating Obligations (NNO)	-13	-12	-17	-11	-18	-18	-19	-16	-38	-91	-60
Total Depreciation and Amortization (D&A)	0.09	0.71	0.11	0.11	0.12	0.75	0.28	0.28	0.28	0.33	0.41
Debt-free, Cash-free Net Working Capital to Revenue	28.03%	14.20%	11.97%	9.82%	-2.30%	-9.82%	7.46%	11.06%	18.62%	-	70.03%
Debt-free Net Working Capital to Revenue	193.80%	151.93%	137.19%	123.17%	111.06%	112.49%	107.36%	38.15%	80.58%	-	90.11%
Net Working Capital to Revenue	193.02%	151.60%	137.11%	121.98%	109.91%	111.61%	106.65%	37.62%	80.16%	-	89.75%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.02)	($322,555,106.06)	$107,908,306.00	$108,438,984.00	$108,438,984.00	($324,786,274.02)	$0.00	$0.00	($0.04)	$0.00	($0.08)
Adjusted Weighted Average Basic Shares Outstanding	106.29M	107.55M	108.44M	108.44M	108.44M	108.59M	113.70M	118.26M	123.41M	123.64M	141.61M
Adjusted Diluted Earnings per Share	($0.02)	($322,555,106.06)	$107,908,306.00	$108,943,126.00	$108,438,984.00	($325,290,416.02)	$0.00	$0.00	($0.04)	$0.00	($0.08)
Adjusted Weighted Average Diluted Shares Outstanding	106.29M	107.55M	108.44M	108.44M	108.44M	108.59M	122.30M	127.22M	123.41M	123.64M	141.61M
Adjusted Basic & Diluted Earnings per Share	($0.02)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	107.65M	0.00	108.44M	108.44M	108.44M	114.63M	117.92M	120.72M	140.04M	143.37M	148.19M
Normalized Net Operating Profit after Tax (NOPAT)	-0.25	-4.66	-0.32	0.04	-0.64	-0.85	0.25	0.01	-3.45	-2.70	-5.26
Normalized NOPAT Margin	-12.34%	-216.58%	-10.32%	1.07%	-24.69%	-12.41%	3.57%	0.13%	-39.62%	-	-77.58%
Pre Tax Income Margin	-8.95%	-234.03%	-10.51%	5.54%	-28.28%	-9.73%	7.81%	1.73%	-54.94%	-	-166.25%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	-12.41%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Augmented Payout Ratio	0.00%	-12.41%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	-33.57%

Financials Breakdown Chart

Key Financial Trends

United States Antimony (NYSE: UAMY) posted a very weak first quarter in 2026, with revenue up sharply from the prior year but losses and cash burn expanding materially. The company generated $6.8 million in revenue, but still reported a net loss of $11.3 million and negative operating cash flow of $12.1 million. That combination suggests the business is growing, but not yet converting that growth into durable profitability or cash generation.

Revenue trends were mixed but improved on a year-over-year basis. Q1 2026 revenue rose to $6.8 million from $3.1 million in Q1 2024, showing meaningful improvement over the last year. However, that was down from the stronger recent quarters in 2025, including $13.0 million in Q4 2025 and $8.7 million in Q3 2025. The latest quarter suggests UAMY can still produce sales growth, but the run rate remains volatile.

Profitability weakened substantially in Q1 2026. Gross profit was only $1.1 million, while operating expenses totaled $8.6 million, resulting in an operating loss of $7.5 million. After other expenses, pre-tax loss reached $11.3 million. This is a sharp deterioration from Q4 2025, when the company’s net loss was only about $0.3 million, and from Q1 2025, when it actually posted a small profit.

Cash flow was also under pressure. UAMY used $12.1 million in operating cash during Q1 2026 and spent another $12.6 million on investing activities, largely tied to property, plant and equipment purchases. Financing activities reduced cash by another $2.6 million. Overall, cash and equivalents fell by $27.3 million during the quarter, a significant decline.

The balance sheet still shows a meaningful equity base, but cash dropped sharply. At March 31, 2026, UAMY held $3.2 million in cash, $4.6 million in short-term investments, and $52.4 million in long-term investments. Total assets were $148.0 million versus total liabilities of only $16.2 million, leaving equity at $131.9 million. That said, the large quarter-over-quarter reduction in cash is worth watching closely.

Revenue nearly doubled year over year in Q1 2026, rising to $6.8 million from $3.1 million in Q1 2024.
Gross profit remained positive at $1.1 million, showing the business can still cover direct production costs.
The balance sheet remains strong on paper, with $148.0 million in assets and $131.9 million in equity.
UAMY still holds a sizable investment portfolio, including $52.4 million in long-term investments.
Q1 2026 revenue was down from the stronger levels seen in Q3 and Q4 2025, indicating some quarter-to-quarter volatility.
Capital spending remained elevated, with $12.6 million used for investing activities in Q1 2026.
The company’s debt load remains modest relative to assets, with only about $161.6 million in total liabilities and very small absolute debt balances.
Operating losses widened sharply to $7.5 million in Q1 2026 from $3.9 million in Q4 2025.
Net loss ballooned to $11.3 million, a major reversal from the small profit posted in Q1 2025.
Operating cash flow was deeply negative at $12.1 million, indicating the business is not yet self-funding.
Cash and equivalents fell by $27.3 million in the quarter, which raises liquidity concerns if losses continue.

Bottom line: UAMY has grown revenue and maintains a substantial asset base, but the latest quarter shows the company is still struggling with profitability and cash generation. Investors will likely want to see whether the large spending and investment activity starts producing better margins and steadier operating cash flow in coming quarters.

07/29/26 12:07 AM ETAI Generated. May Contain Errors.

United States Antimony Financials - Frequently Asked Questions

According to the most recent income statement we have on file, United States Antimony's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

United States Antimony's net income appears to be on an upward trend, with a most recent value of -$4.34 million in 2025, rising from -$838.53 thousand in 2015. The previous period was -$1.73 million in 2024. Check out United States Antimony's forecast to explore projected trends and price targets.

United States Antimony's total operating income in 2025 was -$8.46 million, based on the following breakdown:

Total Gross Profit: $9.87 million
Total Operating Expenses: $18.33 million

Over the last 10 years, United States Antimony's total revenue changed from $13.11 million in 2015 to $39.26 million in 2025, a change of 199.5%.

United States Antimony's total liabilities were at $12.97 million at the end of 2025, a 114.7% increase from 2024, and a 123.6% increase since 2015.

In the past 10 years, United States Antimony's cash and equivalents has ranged from $10.06 thousand in 2016 to $30.49 million in 2025, and is currently $30.49 million as of their latest financial filing in 2025.

Over the last 10 years, United States Antimony's book value per share changed from 0.19 in 2015 to 1.01 in 2025, a change of 435.7%.

Related Companies

Financial statements for NYSE:UAMY last updated on 5/19/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

United States Antimony (UAMY) Financials

Financials Breakdown Chart

Key Financial Trends

United States Antimony Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

United States Antimony (UAMY) Financials

Annual Income Statements for United States Antimony

Quarterly Income Statements for United States Antimony

Annual Cash Flow Statements for United States Antimony

Quarterly Cash Flow Statements for United States Antimony

Annual Balance Sheets for United States Antimony

Quarterly Balance Sheets for United States Antimony

Annual Metrics And Ratios for United States Antimony

Quarterly Metrics And Ratios for United States Antimony

Financials Breakdown Chart

Key Financial Trends

United States Antimony Financials - Frequently Asked Questions

When does United States Antimony's financial year end?

How has United States Antimony's net income changed over the last 10 years?

What is United States Antimony's operating income?

How has United States Antimony's revenue changed over the last 10 years?

How much debt does United States Antimony have?

How much cash does United States Antimony have?

How has United States Antimony's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools